-
1
-
-
0034145982
-
A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST).
-
Ward KM, Aletras AH, Balaban RSA new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST)J Magn Reson 2000, 143:79-87
-
(2000)
J Magn Reson
, vol.143
, pp. 79-87
-
-
Ward, K.M.1
Aletras, A.H.2
Balaban, R.S.3
-
2
-
-
2342511016
-
Quantitative description of proton exchange processes between water and endogenous and exogenous agents for WEX, CEST, and APT experiments.
-
Zhou J, Wilson DA, Sun PZ, Klaus JA, Van Zijl PCQuantitative description of proton exchange processes between water and endogenous and exogenous agents for WEX, CEST, and APT experimentsMagn Reson Med 2004, 51:945-952
-
(2004)
Magn Reson Med
, vol.51
, pp. 945-952
-
-
Zhou, J.1
Wilson, D.A.2
Sun, P.Z.3
Klaus, J.A.4
Van Zijl, P.C.5
-
3
-
-
0035925205
-
A novel europium(III)-based MRI contrast agent.
-
Zhang S, Winter P, Wu K, Sherry ADA novel europium(III)-based MRI contrast agentJ Am Chem Soc 2001, 123:1517-1518
-
(2001)
J Am Chem Soc
, vol.123
, pp. 1517-1518
-
-
Zhang, S.1
Winter, P.2
Wu, K.3
Sherry, A.D.4
-
4
-
-
77956516259
-
CEST and PARACEST MR contrast agents.
-
Hancu I, Dixon WT, Woods M, Vinogradov E, Sherry AD, Lenkinski RECEST and PARACEST MR contrast agentsActa Radiol 2010, 51:910-923
-
(2010)
Acta Radiol
, vol.51
, pp. 910-923
-
-
Hancu, I.1
Dixon, W.T.2
Woods, M.3
Vinogradov, E.4
Sherry, A.D.5
Lenkinski, R.E.6
-
5
-
-
33744523144
-
Paramagnetic lanthanide complexes as PARACEST agents for medical imaging.
-
Woods M, Woessner DE, Sherry ADParamagnetic lanthanide complexes as PARACEST agents for medical imagingChem Soc Rev 2006, 35:500-511
-
(2006)
Chem Soc Rev
, vol.35
, pp. 500-511
-
-
Woods, M.1
Woessner, D.E.2
Sherry, A.D.3
-
6
-
-
84856022354
-
Quantification of water exchange kinetics for targeted PARACEST perfluorocarbon nanoparticles.
-
Cai K, Kiefer GE, Caruthers SD, Wickline SA, Lanza GM, Winter PMQuantification of water exchange kinetics for targeted PARACEST perfluorocarbon nanoparticlesNMR Biomed 2011, 25: 279-285
-
(2011)
NMR Biomed
, vol.25
, pp. 279-285
-
-
Cai, K.1
Kiefer, G.E.2
Caruthers, S.D.3
Wickline, S.A.4
Lanza, G.M.5
Winter, P.M.6
-
7
-
-
0036342449
-
Photocrosslinking characteristics and mechanical properties of diethyl fumarate/poly(propylene fumarate) biomaterials.
-
Fisher JP, Dean D, Mikos AGPhotocrosslinking characteristics and mechanical properties of diethyl fumarate/poly(propylene fumarate) biomaterialsBiomaterials 2002, 23:4333-4343
-
(2002)
Biomaterials
, vol.23
, pp. 4333-4343
-
-
Fisher, J.P.1
Dean, D.2
Mikos, A.G.3
-
8
-
-
41149158587
-
Labeling of adenovirus particles with PARACEST agents.
-
Vasalatiy O, Gerard RD, Zhao P, Sun X, Sherry ADLabeling of adenovirus particles with PARACEST agentsBioconjug Chem 2008, 19:598-606
-
(2008)
Bioconjug Chem
, vol.19
, pp. 598-606
-
-
Vasalatiy, O.1
Gerard, R.D.2
Zhao, P.3
Sun, X.4
Sherry, A.D.5
-
9
-
-
23844439261
-
On-resonance low B1 pulses for imaging of the effects of PARACEST agents.
-
Vinogradov E, Zhang S, Lubag A, Balschi JA, Sherry AD, Lenkinski REOn-resonance low B1 pulses for imaging of the effects of PARACEST agentsJ Magn Reson 2005, 176:54-63
-
(2005)
J Magn Reson
, vol.176
, pp. 54-63
-
-
Vinogradov, E.1
Zhang, S.2
Lubag, A.3
Balschi, J.A.4
Sherry, A.D.5
Lenkinski, R.E.6
-
10
-
-
79959554907
-
In vivo detection of MRI-PARACEST agents in mouse brain tumors at 9.4 T.
-
Li AX, Suchy M, Li C, Gati JS, Meakin S, Hudson RH, Menon RS, Bartha RIn vivo detection of MRI-PARACEST agents in mouse brain tumors at 9.4 TMagn Reson Med 2011, 66:67-72
-
(2011)
Magn Reson Med
, vol.66
, pp. 67-72
-
-
Li, A.X.1
Suchy, M.2
Li, C.3
Gati, J.S.4
Meakin, S.5
Hudson, R.H.6
Menon, R.S.7
Bartha, R.8
-
11
-
-
60549107250
-
PARACEST MRI with improved temporal resolution.
-
Liu G, Ali MM, Yoo B, Griswold MA, Tkach JA, Pagel MDPARACEST MRI with improved temporal resolutionMagn Reson Med 2009, 61:399-408
-
(2009)
Magn Reson Med
, vol.61
, pp. 399-408
-
-
Liu, G.1
Ali, M.M.2
Yoo, B.3
Griswold, M.A.4
Tkach, J.A.5
Pagel, M.D.6
-
12
-
-
84857365037
-
Measuring in vivo tumor pHe with CEST-FISP MRI.
-
Sheth VR, Li Y, Chen LQ, Howison CM, Flask CA, Pagel MDMeasuring in vivo tumor pHe with CEST-FISP MRIMagn Reson Med 2011, 67:760-768
-
(2011)
Magn Reson Med
, vol.67
, pp. 760-768
-
-
Sheth, V.R.1
Li, Y.2
Chen, L.Q.3
Howison, C.M.4
Flask, C.A.5
Pagel, M.D.6
-
13
-
-
24644481042
-
Highly sensitive MRI chemical exchange saturation transfer agents using liposomes.
-
Aime S, Delli Castelli D, Terreno EHighly sensitive MRI chemical exchange saturation transfer agents using liposomesAngew Chem Int Ed Engl 2005, 44:5513-5515
-
(2005)
Angew Chem Int Ed Engl
, vol.44
, pp. 5513-5515
-
-
Aime, S.1
Delli Castelli, D.2
Terreno, E.3
-
14
-
-
33847685866
-
Gd-loaded liposomes as T1, susceptibility, and CEST agents, all in one.
-
Aime S, Delli Castelli D, Lawson D, Terreno EGd-loaded liposomes as T1, susceptibility, and CEST agents, all in oneJ Am Chem Soc 2007, 129: 2430-2431
-
(2007)
J Am Chem Soc
, vol.129
, pp. 2430-2431
-
-
Aime, S.1
Delli Castelli, D.2
Lawson, D.3
Terreno, E.4
-
15
-
-
33846696781
-
From spherical to osmotically shrunken paramagnetic liposomes: an improved generation of LIPOCEST MRI agents with highly shifted water protons.
-
Terreno E, Cabella C, Carrera C, Delli Castelli D, Mazzon R, Rollet S, Stancanello J, Visigalli M, Aime SFrom spherical to osmotically shrunken paramagnetic liposomes: an improved generation of LIPOCEST MRI agents with highly shifted water protonsAngew Chem Int Ed Engl 2007, 46:966-968
-
(2007)
Angew Chem Int Ed Engl
, vol.46
, pp. 966-968
-
-
Terreno, E.1
Cabella, C.2
Carrera, C.3
Delli Castelli, D.4
Mazzon, R.5
Rollet, S.6
Stancanello, J.7
Visigalli, M.8
Aime, S.9
-
16
-
-
43149121586
-
Lanthanide-loaded paramagnetic liposomes as switchable magnetically oriented nanovesicles.
-
Delli Castelli D, Terreno E, Carrera C, Giovenzana GB, Mazzon R, Rollet S, Visigalli M, Aime SLanthanide-loaded paramagnetic liposomes as switchable magnetically oriented nanovesiclesInorg Chem 2008, 47:2928-2930
-
(2008)
Inorg Chem
, vol.47
, pp. 2928-2930
-
-
Delli Castelli, D.1
Terreno, E.2
Carrera, C.3
Giovenzana, G.B.4
Mazzon, R.5
Rollet, S.6
Visigalli, M.7
Aime, S.8
-
17
-
-
38349096517
-
Highly shifted LIPOCEST agents based on the encapsulation of neutral polynuclear paramagnetic shift reagents.
-
Terreno E, Barge A, Beltrami L, Cravotto G, Castelli DD, Fedeli F, Jebasingh B, Aime SHighly shifted LIPOCEST agents based on the encapsulation of neutral polynuclear paramagnetic shift reagentsChem Commun (Camb) 2008, 5:600-602
-
(2008)
Chem Commun (Camb)
, vol.5
, pp. 600-602
-
-
Terreno, E.1
Barge, A.2
Beltrami, L.3
Cravotto, G.4
Castelli, D.D.5
Fedeli, F.6
Jebasingh, B.7
Aime, S.8
-
18
-
-
84859104671
-
In vivo multicolor molecular MR imaging using diamagnetic chemical exchange saturation transfer liposomes.
-
doi:10.1002/mrm.23100
-
Liu G, Moake M, Har-el Y-E, Long CM, Chan KW, Cardona A, Jamil M, Walczak P, Gilad AA, Sgouros G, et alIn vivo multicolor molecular MR imaging using diamagnetic chemical exchange saturation transfer liposomesMagn Reson Med 2012doi:10.1002/mrm.23100
-
(2012)
Magn Reson Med
-
-
Liu, G.1
Moake, M.2
Har-el, Y.-E.3
Long, C.M.4
Chan, K.W.5
Cardona, A.6
Jamil, M.7
Walczak, P.8
Gilad, A.A.9
Sgouros, G.10
-
19
-
-
0038101642
-
Sensitive CEST agents based on nucleic acid imino proton exchange: detection of poly(rU) and of a dendrimer-poly(rU) model for nucleic acid delivery and pharmacology.
-
Snoussi K, Bulte JW, Gueron M, van Zijl PCSensitive CEST agents based on nucleic acid imino proton exchange: detection of poly(rU) and of a dendrimer-poly(rU) model for nucleic acid delivery and pharmacologyMagn Reson Med 2003, 49:998-1005
-
(2003)
Magn Reson Med
, vol.49
, pp. 998-1005
-
-
Snoussi, K.1
Bulte, J.W.2
Gueron, M.3
van Zijl, P.C.4
-
20
-
-
81255127569
-
Multimodal imaging of sustained drug release from 3-D poly(propylene fumarate) (PPF) scaffolds.
-
Choi J, Kim K, Kim T, Liu G, Bar-Shir A, Hyeon T, McMahon MT, Bulte JW, Fisher JP, Gilad AAMultimodal imaging of sustained drug release from 3-D poly(propylene fumarate) (PPF) scaffoldsJ Control Release 2011, 156:239-245
-
(2011)
J Control Release
, vol.156
, pp. 239-245
-
-
Choi, J.1
Kim, K.2
Kim, T.3
Liu, G.4
Bar-Shir, A.5
Hyeon, T.6
McMahon, M.T.7
Bulte, J.W.8
Fisher, J.P.9
Gilad, A.A.10
-
21
-
-
63149146713
-
A temperature-sensitive liposomal 1H CEST and 19F contrast agent for MR image-guided drug delivery.
-
Langereis S, Keupp J, van Velthoven JL, de Roos IH, Burdinski D, Pikkemaat JA, Grull HA temperature-sensitive liposomal 1H CEST and 19F contrast agent for MR image-guided drug deliveryJ Am Chem Soc 2009, 131:1380-1381
-
(2009)
J Am Chem Soc
, vol.131
, pp. 1380-1381
-
-
Langereis, S.1
Keupp, J.2
van Velthoven, J.L.3
de Roos, I.H.4
Burdinski, D.5
Pikkemaat, J.A.6
Grull, H.7
-
22
-
-
70350049069
-
Tracking the relative in vivo pharmacokinetics of nanoparticles with PARACEST MRI.
-
Ali MM, Yoo B, Pagel MDTracking the relative in vivo pharmacokinetics of nanoparticles with PARACEST MRIMol Pharm 2009, 6:1409-1416
-
(2009)
Mol Pharm
, vol.6
, pp. 1409-1416
-
-
Ali, M.M.1
Yoo, B.2
Pagel, M.D.3
-
23
-
-
33845259382
-
Targeted PARACEST nanoparticle contrast agent for the detection of fibrin.
-
Winter PM, Cai K, Chen J, Adair CR, Kiefer GE, Athey PS, Gaffney PJ, Buff CE, Robertson JD, Caruthers SD, et alTargeted PARACEST nanoparticle contrast agent for the detection of fibrinMagn Reson Med 2006, 56:1384-1388
-
(2006)
Magn Reson Med
, vol.56
, pp. 1384-1388
-
-
Winter, P.M.1
Cai, K.2
Chen, J.3
Adair, C.R.4
Kiefer, G.E.5
Athey, P.S.6
Gaffney, P.J.7
Buff, C.E.8
Robertson, J.D.9
Caruthers, S.D.10
-
24
-
-
84863154445
-
Imaging In vivo extracellular pH with a single paramagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent.
-
doi:10.2310/7290.2011.00026
-
Liu G, Li Y, Sheth VR, Pagel MDImaging In vivo extracellular pH with a single paramagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agentMol Imaging 2011doi:10.2310/7290.2011.00026
-
(2011)
Mol Imaging
-
-
Liu, G.1
Li, Y.2
Sheth, V.R.3
Pagel, M.D.4
-
25
-
-
80051938706
-
A self-calibrating PARACEST MRI contrast agent that detects esterase enzyme activity.
-
Li Y, Sheth VR, Liu G, Pagel MDA self-calibrating PARACEST MRI contrast agent that detects esterase enzyme activityContrast Media Mol Imaging 2011, 6:219-228
-
(2011)
Contrast Media Mol Imaging
, vol.6
, pp. 219-228
-
-
Li, Y.1
Sheth, V.R.2
Liu, G.3
Pagel, M.D.4
-
26
-
-
36849044069
-
Design and characterization of a new irreversible responsive PARACEST MRI contrast agent that detects nitric oxide.
-
Liu G, Li Y, Pagel MDDesign and characterization of a new irreversible responsive PARACEST MRI contrast agent that detects nitric oxideMagn Reson Med 2007, 58:1249-1256
-
(2007)
Magn Reson Med
, vol.58
, pp. 1249-1256
-
-
Liu, G.1
Li, Y.2
Pagel, M.D.3
-
27
-
-
33750434288
-
A PARACEST MRI contrast agent to detect enzyme activity.
-
Yoo B, Pagel MDA PARACEST MRI contrast agent to detect enzyme activityJ Am Chem Soc 2006, 128:14032-14033
-
(2006)
J Am Chem Soc
, vol.128
, pp. 14032-14033
-
-
Yoo, B.1
Pagel, M.D.2
-
28
-
-
38649103503
-
Dendritic PARACEST contrast agents for magnetic resonance imaging.
-
Pikkemaat JA, Wegh RT, Lamerichs R, van de Molengraaf RA, Langereis S, Burdinski D, Raymond AY, Janssen HM, de Waal BF, Willard NP, et alDendritic PARACEST contrast agents for magnetic resonance imagingContrast Media Mol Imaging 2007, 2:229-239
-
(2007)
Contrast Media Mol Imaging
, vol.2
, pp. 229-239
-
-
Pikkemaat, J.A.1
Wegh, R.T.2
Lamerichs, R.3
van de Molengraaf, R.A.4
Langereis, S.5
Burdinski, D.6
Raymond, A.Y.7
Janssen, H.M.8
de Waal, B.F.9
Willard, N.P.10
-
29
-
-
34047120769
-
Emerging nanomedicine opportunities with perfluorocarbon nanoparticles.
-
Winter PM, Cai K, Caruthers SD, Wickline SA, Lanza GMEmerging nanomedicine opportunities with perfluorocarbon nanoparticlesExpert Rev Med Devices 2007, 4:137-145
-
(2007)
Expert Rev Med Devices
, vol.4
, pp. 137-145
-
-
Winter, P.M.1
Cai, K.2
Caruthers, S.D.3
Wickline, S.A.4
Lanza, G.M.5
-
30
-
-
77955119834
-
Molecular imaging of angiogenic therapy in peripheral vascular disease with ανβ3-integrin-targeted nanoparticles.
-
Winter PM, Caruthers SD, Allen JS, Cai K, Williams TA, Lanza GM, Wickline SAMolecular imaging of angiogenic therapy in peripheral vascular disease with ανβ3-integrin-targeted nanoparticlesMagn Reson Med 2010, 64:369-376
-
(2010)
Magn Reson Med
, vol.64
, pp. 369-376
-
-
Winter, P.M.1
Caruthers, S.D.2
Allen, J.S.3
Cai, K.4
Williams, T.A.5
Lanza, G.M.6
Wickline, S.A.7
-
31
-
-
0141731298
-
Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel α(ν)β3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging.
-
Winter PM, Caruthers SD, Kassner A, Harris TD, Chinen LK, Allen JS, Lacy EK, Zhang H, Robertson JD, Wickline SA, et alMolecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel α(ν)β3-targeted nanoparticle and 1.5 tesla magnetic resonance imagingCancer Res 2003, 63:5838-5843
-
(2003)
Cancer Res
, vol.63
, pp. 5838-5843
-
-
Winter, P.M.1
Caruthers, S.D.2
Kassner, A.3
Harris, T.D.4
Chinen, L.K.5
Allen, J.S.6
Lacy, E.K.7
Zhang, H.8
Robertson, J.D.9
Wickline, S.A.10
-
32
-
-
51549084986
-
Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis.
-
Winter PM, Caruthers SD, Zhang H, Williams TA, Wickline SA, Lanza GMAntiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosisJACC Cardiovasc Imaging 2008, 1:624-634
-
(2008)
JACC Cardiovasc Imaging
, vol.1
, pp. 624-634
-
-
Winter, P.M.1
Caruthers, S.D.2
Zhang, H.3
Williams, T.A.4
Wickline, S.A.5
Lanza, G.M.6
-
33
-
-
0242266976
-
Molecular imaging of angiogenesis in early-stage atherosclerosis with α(ν)β3-integrin-targeted nanoparticles.
-
Winter PM, Morawski AM, Caruthers SD, Fuhrhop RW, Zhang H, Williams TA, Allen JS, Lacy EK, Robertson JD, Lanza GM, et alMolecular imaging of angiogenesis in early-stage atherosclerosis with α(ν)β3-integrin-targeted nanoparticlesCirculation 2003, 108:2270-2274
-
(2003)
Circulation
, vol.108
, pp. 2270-2274
-
-
Winter, P.M.1
Morawski, A.M.2
Caruthers, S.D.3
Fuhrhop, R.W.4
Zhang, H.5
Williams, T.A.6
Allen, J.S.7
Lacy, E.K.8
Robertson, J.D.9
Lanza, G.M.10
-
34
-
-
33747429423
-
Endothelial α(ν)β3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis.
-
Winter PM, Neubauer AM, Caruthers SD, Harris TD, Robertson JD, Williams TA, Schmieder AH, Hu G, Allen JS, Lacy EK, et alEndothelial α(ν)β3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosisArterioscler Thromb Vasc Biol 2006, 26:2103-2109
-
(2006)
Arterioscler Thromb Vasc Biol
, vol.26
, pp. 2103-2109
-
-
Winter, P.M.1
Neubauer, A.M.2
Caruthers, S.D.3
Harris, T.D.4
Robertson, J.D.5
Williams, T.A.6
Schmieder, A.H.7
Hu, G.8
Allen, J.S.9
Lacy, E.K.10
-
35
-
-
48749099374
-
Minute dosages of α(ν)β3-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbits.
-
Winter PM, Schmieder AH, Caruthers SD, Keene JL, Zhang H, Wickline SA, Lanza GMMinute dosages of α(ν)β3-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbitsFASEB J 2008, 22:2758-2767
-
(2008)
FASEB J
, vol.22
, pp. 2758-2767
-
-
Winter, P.M.1
Schmieder, A.H.2
Caruthers, S.D.3
Keene, J.L.4
Zhang, H.5
Wickline, S.A.6
Lanza, G.M.7
-
36
-
-
0035845635
-
Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques.
-
Flacke S, Fischer S, Scott MJ, Fuhrhop RJ, Allen JS, McLean M, Winter P, Sicard GA, Gaffney PJ, Wickline SA, et alNovel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaquesCirculation 2001, 104:1280-1285
-
(2001)
Circulation
, vol.104
, pp. 1280-1285
-
-
Flacke, S.1
Fischer, S.2
Scott, M.J.3
Fuhrhop, R.J.4
Allen, J.S.5
McLean, M.6
Winter, P.7
Sicard, G.A.8
Gaffney, P.J.9
Wickline, S.A.10
-
37
-
-
0041590985
-
Improved molecular imaging contrast agent for detection of human thrombus.
-
Winter PM, Caruthers SD, Yu X, Song SK, Chen J, Miller B, Bulte JW, Robertson JD, Gaffney PJ, Wickline SA, et alImproved molecular imaging contrast agent for detection of human thrombusMagn Reson Med 2003, 50:411-416
-
(2003)
Magn Reson Med
, vol.50
, pp. 411-416
-
-
Winter, P.M.1
Caruthers, S.D.2
Yu, X.3
Song, S.K.4
Chen, J.5
Miller, B.6
Bulte, J.W.7
Robertson, J.D.8
Gaffney, P.J.9
Wickline, S.A.10
-
38
-
-
10044277164
-
Quantitative "magnetic resonance immunohistochemistry" with ligand-targeted (19)F nanoparticles.
-
Morawski AM, Winter PM, Yu X, Fuhrhop RW, Scott MJ, Hockett F, Robertson JD, Gaffney PJ, Lanza GM, Wickline SAQuantitative "magnetic resonance immunohistochemistry" with ligand-targeted (19)F nanoparticlesMagn Reson Med 2004, 52:1255-1262
-
(2004)
Magn Reson Med
, vol.52
, pp. 1255-1262
-
-
Morawski, A.M.1
Winter, P.M.2
Yu, X.3
Fuhrhop, R.W.4
Scott, M.J.5
Hockett, F.6
Robertson, J.D.7
Gaffney, P.J.8
Lanza, G.M.9
Wickline, S.A.10
-
39
-
-
55749093222
-
Gadolinium-modulated 19F signals from perfluorocarbon nanoparticles as a new strategy for molecular imaging.
-
Neubauer AM, Myerson J, Caruthers SD, Hockett FD, Winter PM, Chen J, Gaffney PJ, Robertson JD, Lanza GM, Wickline SAGadolinium-modulated 19F signals from perfluorocarbon nanoparticles as a new strategy for molecular imagingMagn Reson Med 2008, 60:1066-1072
-
(2008)
Magn Reson Med
, vol.60
, pp. 1066-1072
-
-
Neubauer, A.M.1
Myerson, J.2
Caruthers, S.D.3
Hockett, F.D.4
Winter, P.M.5
Chen, J.6
Gaffney, P.J.7
Robertson, J.D.8
Lanza, G.M.9
Wickline, S.A.10
-
40
-
-
0036204319
-
Paramagnetic lanthanide(III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications.
-
Aime S, Barge A, Delli Castelli D, Fedeli F, Mortillaro A, Nielsen FU, Terreno EParamagnetic lanthanide(III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applicationsMagn Reson Med 2002, 47:639-648
-
(2002)
Magn Reson Med
, vol.47
, pp. 639-648
-
-
Aime, S.1
Barge, A.2
Delli Castelli, D.3
Fedeli, F.4
Mortillaro, A.5
Nielsen, F.U.6
Terreno, E.7
-
41
-
-
1642351484
-
Ln(III)-DOTAMGly complexes: a versatile series to assess the determinants of the efficacy of paramagnetic chemical exchange saturation transfer agents for magnetic resonance imaging applications.
-
Terreno E, Castelli DD, Cravotto G, Milone L, Aime SLn(III)-DOTAMGly complexes: a versatile series to assess the determinants of the efficacy of paramagnetic chemical exchange saturation transfer agents for magnetic resonance imaging applicationsInvest Radiol 2004, 39:235-243
-
(2004)
Invest Radiol
, vol.39
, pp. 235-243
-
-
Terreno, E.1
Castelli, D.D.2
Cravotto, G.3
Milone, L.4
Aime, S.5
-
42
-
-
29344462452
-
MRI thermometry based on PARACEST agents.
-
Zhang S, Malloy CR, Sherry ADMRI thermometry based on PARACEST agentsJ Am Chem Soc 2005, 127:17572-17573
-
(2005)
J Am Chem Soc
, vol.127
, pp. 17572-17573
-
-
Zhang, S.1
Malloy, C.R.2
Sherry, A.D.3
-
43
-
-
0037077538
-
A paramagnetic MRI-CEST agent responsive to lactate concentration.
-
Aime S, Delli Castelli D, Fedeli F, Terreno EA paramagnetic MRI-CEST agent responsive to lactate concentrationJ Am Chem Soc 2002, 124:9364-9365
-
(2002)
J Am Chem Soc
, vol.124
, pp. 9364-9365
-
-
Aime, S.1
Delli Castelli, D.2
Fedeli, F.3
Terreno, E.4
-
44
-
-
9244257907
-
Cyclen-based phenylboronate ligands and their Eu3+ complexes for sensing glucose by MRI.
-
Trokowski R, Zhang S, Sherry ADCyclen-based phenylboronate ligands and their Eu3+ complexes for sensing glucose by MRIBioconjug Chem 2004, 15:1431-1440
-
(2004)
Bioconjug Chem
, vol.15
, pp. 1431-1440
-
-
Trokowski, R.1
Zhang, S.2
Sherry, A.D.3
-
45
-
-
27544442676
-
Selective sensing of zinc ions with a PARACEST contrast agent.
-
Trokowski R, Ren J, Kalman FK, Sherry ADSelective sensing of zinc ions with a PARACEST contrast agentAngew Chem Int Ed Engl 2005, 44:6920-6923
-
(2005)
Angew Chem Int Ed Engl
, vol.44
, pp. 6920-6923
-
-
Trokowski, R.1
Ren, J.2
Kalman, F.K.3
Sherry, A.D.4
|